• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jane C. Weeks, M.D. M.Sc. Sc.M.

Professor, Department of Medicine, Harvard Medical School

Professor, Department of Health Policy and Management, Harvard School Of Public Health

Chief, Population Science, Dana-Farber Cancer Institute

Contact Info

Jane Weeks
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Building 454, Suite 21
Phone: 617-632-2509
Fax: 617-632-2270
jane_weeks@dfci.harvard.edu

Assistant

Susan Aoki
Administrative Specialist
Population Sciences
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SM271
Phone: 617-632-4351
Fax: 617-632-2270
susan_aoki@dfci.harvard.edu

DF/HCC Program Affiliation

Breast Cancer
Outcomes Research, Co-Leader
Palliative Care
Lung Cancer
Lymphoma and Myeloma

DF/HCC Associations

Member, Center Scientific Council

Research Abstract

Dr. Weeks' research focuses on assessing the outcomes and cost effectiveness of cancer therapy. She is the Principal Investigator of one of the NCI-funded CanCORS studies examining the quality and outcomes of care for patients with lung and colorectal cancer across the US. She is also the Principal Investigator of the National Comprehensive Cancer Network (NCCN) Outcomes Project. In this role, she directs the collection and analysis of data on the clinical characteristics, treatment, and outcomes of cancer patients cared for in NCCN centers. She chairs the Clinical Economics Subcommittee of the CALGB, and is the lead investigator on a number of economic analyses alongside clinical trials in that group. Her primary methodologic interest is in assessing patients’ preferences for use in treatment and policy decision-making.

Publications

  • Lamont EB, Herndon JE, Weeks JC, Henderson IC, Earle CC, Schilsky RL, Christakis NA,.Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).J Natl Cancer Inst 2006 Sep 20;98
    16985253
  • Punglia RS, Weeks JC, Neville BA, Earle CC.Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.J Clin Oncol 2006 Jul 20;24(21):3474-82.
    16849764
  • Punglia RS, Weeks JC, Neville BA, Earle CC.Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.Int J Radiat Oncol Biol Phys 2006 Jun 29.
    16814955
  • Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.Cancer 2006 Jun 15;106(12):2576-82
    16703595
  • Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC.A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.Ann Surg
    16432358
  • Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC.The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.J Clin Oncol 2006 Jan 20;24(3):361-9.
    16421417
  • Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G,.Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial.JAMA 2002 Jan 16;287(3):321-8.
    11790211
  • Burstein HJ, Gelber S, Guadagnoli E, Weeks JC.Use of alternative medicine by women with early-stage breast cancer.N Engl J Med 1999 Jun 3;340(22):1733-9.
    10352166
  • Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF, Lynn J, Phillips RS.Relationship between cancer patients' predictions of prognosis and their treatment preferences.JAMA 1998 Jun 3;279(21):1709-14.
    9624023
  • Schrag D, Kuntz KM, Garber JE, Weeks JC.Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.N Engl J Med 1997 May 15;336(20):1465-71.
    9148160
  • Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC.Factors Associated with Guideline-Concordant Use of Radiotherapy After Mastectomy in the National Comprehensive Cancer Network.Int J Radiat Oncol Biol Phy
    18472360
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS.Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study.Radiology 2008 May 5.
    18458247
  • Punglia RS, Burstein HJ, Winer EP, Weeks JC.Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.Journal of the National Cancer Institute 2008 May 7;100(9):642-8.
    18445827
  • Lamont EB, Herndon JE 2nd, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA.Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.Med Care 2008 Mar
    18388845
  • Greenberg CC, Schneider EC, Lipsitz SR, Ko CY, Malin JL, Epstein AM, Weeks JC, Kahn KL.Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction?.J Am Coll Surg 2008 Apr;206(4):605-15.
    18387464
  • Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J, Aldridge SA, Grier HE, Berde C, Dussel V, Weeks JC.Easing of suffering in children with cancer at the end of life: is care changing?.J Clin Oncol 2008 Apr 1;26(10):1717-23.
    18375901
  • Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.Journal of the Nati
    18270338
  • Greenberg CC, Weeks JC, Stain SC.Disparities in oncologic surgery.World J Surg 2008 Apr;32(4):522-8.
    18197450
  • Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC.Hope and prognostic disclosure.J Clin Oncol 2007 Dec 10;25(35):5636-42.
    18065734
  • Albritton KH, Wiggins CH, Nelson HE, Weeks JC.Site of oncologic specialty care for older adolescents in Utah.J Clin Oncol 2007 Oct 10;25(29):4616-21.
    17925557
  • Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC.Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.J Clin On
    17577019
  • Steyerberg EW, Neville B, Weeks JC, Earle CC.Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients.J Clin Oncol 2007 Jun 10;25(17):2389-96.
    17557952
  • Mack JW, Cook EF, Wolfe J, Grier HE, Cleary PD, Weeks JC.Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction.J Clin Oncol 2007 Apr 10;25(11):1357-62.
    17416854
  • Abel GA, Lee SJ, Weeks JC.Direct-to-consumer advertising in oncology: a content analysis of print media.J Clin Oncol 2007 Apr 1;25(10):1267-71.
    17401016
  • Falconer AD, Hirschowitz L, Weeks J, Murdoch J,.The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997-2002).BJOG 2007 Apr;114(4):391-7.
    17378814
  • Krzyzanowska MK, Earle CC, Kuntz KM, Weeks JC.Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.Int J Radiat Oncol Biol Phys 2007 Jan 1;67(1):211-8.
    17189071
  • Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC.Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information.J Clin Oncol 2006 Nov 20;24(33):5265-70.
    17114660
  • Steyerberg EW, Neville BA, Koppert LB, Lemmens VE, Tilanus HW, Coebergh JW, Weeks JC, Earle CC.Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score.J Clin Oncol 2006 Sep 10;24(26):4277-84.
    16963730
  • Oh WK, Hayes J, Evan C, Manola J, George DJ, Waldron H, Donovan M, Varner J, Orechia J, Katcher B, Lu D, Nevins A, Wright RL, Tormey L, Talcott J, Rubin MA, Loda M, Sellers WR, Richie JP, Kantoff PW, Weeks J.Development of an integrated prostate cancer re
    16859581
  • Paskett ED, Schrag D, Kornblith A, Lamont EB, Weeks JC, Marshall JR, Shapiro C, Holland J.Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.Clin Cancer Res 2006 Jun 1;12(11 Pt 2):3601s-5s.
    16740792
  • Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ.Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, qu
    16505413
  • Emmons KM, Puleo E, Park E, Gritz ER, Butterfield RM, Weeks JC, Mertens A, Li FP.Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study.J Clin Oncol 2005 Sep 20;23(27):6516-23.
    16116148
  • Lamont EB, Herndon JE, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA.Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.J Natl Cancer Inst 2005 Jul 20;97(14):1080-3
    16030306
  • Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.J Clin Oncol 2005 Aug 1;23(22):5178-87.
    15998905
  • Earle CC, Neville BA, Beth Landrum M, Souza JM, Weeks JC, Block SD, Grunfeld E, Ayanian JZ.Evaluating claims-based indicators of the intensity of end-of-life cancer care.Int J Qual Health Care 2005 Jun 28.
    15985505
  • Emmons KM, Stoddard AM, Fletcher R, Gutheil C, Suarez EG, Lobb R, Weeks J, Bigby JA.Cancer prevention among working class, multiethnic adults: results of the healthy directions-health centers study.Am J Public Health 2005 Jul;95(7):1200-5.
    15933240
  • Steyerberg EW, Earle CC, Neville BA, Weeks JC.Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients.J Clin Oncol 2005 Jan 20;23(3):510-7.
    15659496
  • Ayanian JZ, Chrischilles EA, Wallace RB, Fletcher RH, Fouad MN, Kiefe CI, Harrington DP, Weeks JC, Kahn KL, Malin JL, Lipscomb J, Potosky AL, Provenzale DT, Sandler RS, Van Ryn M, West DW.Understanding cancer treatment and outcomes: the cancer care outcom
    15284250
  • Joffe S, Harrington DP, George SL, Emanuel EJ, Budzinski LA, Weeks JC.Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis.BMJ 2004 Jun 19;328(7454):1463.
    15163611
  • Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ.When does quality-adjusting life-years matter in cost-effectiveness analysis?.Health Econ 2004 May;13(5):429-36.
    15127423
  • Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC.HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.J Clin Oncol 2004 Mar 1;22(5):854-63.
    14990641
  • Ng AK, Li S, Neuberg D, Silver B, Weeks J, Mauch P.Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians.Ann Oncol 2004 Feb;15(2):261-9.
    14760120
  • Peppercorn JM, Weeks JC, Cook EF, Joffe S.Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.Lancet 2004 Jan 24;363(9405):263-70.
    14751698
  • Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC.Trends in the aggressiveness of cancer care near the end of life.J Clin Oncol 2004 Jan 15;22(2):315-21.
    14722041
  • Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RJ, Willett CG, MacDonald JS, Benson AB, Fuchs CS.Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curativ
    14701779
  • Hunt MK, Stoddard AM, Barbeau E, Goldman R, Wallace L, Gutheil C, Sorensen G.Cancer prevention for working class, multiethnic populations through small businesses: the healthy directions study.Cancer Causes Control 2003 Oct;14(8):749-60.
    14674739
  • Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC.Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers.J Natl Cancer Inst 2003 Oct 15;95(20):1514-21.
    14559873
  • Weeks JC.Thinking globally, acting locally: steroid hormone regulation of the dendritic architecture, synaptic connectivity and death of an individual neuron.Prog Neurobiol 2003 Aug;70(5):421-42.
    14511700
  • Krzyzanowska MK, Weeks JC, Earle CC.Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness.J Clin Oncol 2003 Sep 15;21(18):3409-14.
    12972517
  • Ng AK, Li S, Neuberg D, Silver B, Weeks JC, Mauch PM.Factors influencing treatment decision in early-stage Hodgkin disease: a physician survey.Int J Radiat Oncol Biol Phys 2003 Oct 1;57(2 Suppl):S213-4.
    12965477
  • Betensky RA, Talcott JA, Weeks JC.Binary data with two, non-nested sources of clustering: an analysis of physician recommendations for early prostate cancer treatment.Biostatistics 2000 Jun;1(2):219-30.
    12933521
  • Keating NL, Weeks JC, Borbas C, Guadagnoli E.Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed?.Breast Cancer Res Treat 2003 May;79(2):225-31.
    12825857
  • Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC.Optimistic expectations and survival after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant 2003 Jun;9(6):389-96.
    12813447
  • Goldman DP, Berry SH, McCabe MS, Kilgore ML, Potosky AL, Schoenbaum ML, Schonlau M, Weeks JC, Kaplan R, Escarce JJ.Incremental treatment costs in national cancer institute-sponsored clinical trials.JAMA 2003 Jun 11;289(22):2970-7.
    12799405
  • Hadley J, Mandelblatt JS, Mitchell JM, Weeks JC, Guadagnoli E, Hwang YT,.Medicare breast surgery fees and treatment received by older women with localized breast cancer.Health Serv Res 2003 Apr;38(2):553-73.
    12785561
  • Earle CC, Burstein HJ, Winer EP, Weeks JC.Quality of non-breast cancer health maintenance among elderly breast cancer survivors.J Clin Oncol 2003 Apr 15;21(8):1447-51.
    12697865
  • Joffe S, Manocchia M, Weeks JC, Cleary PD.What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics.J Med Ethics 2003 Apr;29(2):103-8.
    12672891
  • Polsky D, Mandelblatt JS, Weeks JC, Venditti L, Hwang YT, Glick HA, Hadley J, Schulman KA.Economic evaluation of breast cancer treatment: considering the value of patient choice.J Clin Oncol 2003 Mar 15;21(6):1139-46.
    12637482
  • Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S.Identifying potential indicators of the quality of end-of-life cancer care from administrative data.J Clin Oncol 2003 Mar 15;21(6):1133-8.
    12637481
  • Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson BM, Hwang YT, Kerner J, Weeks J.Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care.J Clin Oncol 2003 Mar 1;21(5):855-63.
    12610185
  • Hadley J, Polsky D, Mandelblatt JS, Mitchell JM, Weeks JC, Wang Q, Hwang YT,.An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.Health Econ 2003 Mar;12(3):171-86.
    12605463
  • Joffe S, Weeks JC.Views of American oncologists about the purposes of clinical trials.J Natl Cancer Inst 2002 Dec 18;94(24):1847-53.
    12488478
  • Melville JM, Hoffman KL, Jarrard HE, Weeks JC.Cell culture of mechanoreceptor neurons innervating proleg sensory hairs in Manduca sexta larvae, and co-culture with target motoneurons.Cell Tissue Res 2003 Jan;311(1):117-30.
    12483291
  • Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Hwang YT, Weeks JC.Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma.Cancer 2002 Dec 15;95(12):2445-54.
    12467056
  • Grunberg SM, Srivastava A, Grunberg KJ, Weeks J.Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.Support Care Cancer 2002 Nov;10(8):624-9.
    12436221
  • Polsky D, Keating NL, Weeks JC, Schulman KA.Patient choice of breast cancer treatment: impact on health state preferences.Med Care 2002 Nov;40(11):1068-79.
    12409852
  • Lehmann LS, Weeks JC, Klar N, Garber JE.A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.Genet Med 2002 Sep-Oct;4(5):346-52.
    12394347
  • Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ.Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.J Clin Oncol 2002 Apr 15;20(8):2118-26.
    11956273
  • Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC.Impact of referral patterns on the use of chemotherapy for lung cancer.J Clin Oncol 2002 Apr 1;20(7):1786-92.
    11919235
  • Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC.Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement?.J Clin Oncol 2002 Mar 15;20(6):1473-9.
    11896094
  • Kilbridge KL, Cole BF, Kirkwood JM, Haluska FG, Atkins MA, Ruckdeschel JC, Sock DE, Nease RF, Weeks JC.Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial dat
    11870174
  • Liang W, Burnett CB, Rowland JH, Meropol NJ, Eggert L, Hwang YT, Silliman RA, Weeks JC, Mandelblatt JS.Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction.J Clin Oncol 2002 Feb
    11844824
  • Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC.Quality of informed consent in cancer clinical trials: a cross-sectional survey.Lancet 2001 Nov 24;358(9295):1772-7.
    11734235
  • Gurwitz JH, Guadagnoli E, Landrum MB, Silliman RA, Wolf R, Weeks JC.The treating physician as active gatekeeper in the recruitment of research subjects.Med Care 2001 Dec;39(12):1339-44.
    11717575
  • Keating NL, Weeks JC, Landrum MB, Borbas C, Guadagnoli E.Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction.Med Care 2001 Jul;39(7):681-91.
    11458133
  • Ng AK, Kuntz KM, Mauch PM, Weeks JC.Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease.Int J Radiat Oncol Biol Phys 2001 Jul 15;50(4):979-89.
    11429226
  • Lee SJ, Fairclough D, Antin JH, Weeks JC.Discrepancies between patient and physician estimates for the success of stem cell transplantation.JAMA 2001 Feb 28;285(8):1034-8.
    11209174
  • Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC.Quality of informed consent: a new measure of understanding among research subjects.J Natl Cancer Inst 2001 Jan 17;93(2):139-47.
    11208884
  • Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC.Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.J Clin Oncol 2001 Feb 15;19(4):1064-70.
    11181670
  • Kilbridge KL, Weeks JC, Sober AJ, Haluska FG, Slingluff CL, Atkins MB, Sock DE, Kirkwood JM, Nease RF.Patient preferences for adjuvant interferon alfa-2b treatment.J Clin Oncol 2001 Feb 1;19(3):812-23.
    11157035
  • Lehmann LS, Weeks JC, Klar N, Biener L, Garber JE.Disclosure of familial genetic information: perceptions of the duty to inform.Am J Med 2000 Dec 15;109(9):705-11.
    11137485
  • Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, Antin JH, Weeks JC.Recovery after stem-cell transplantation for hematologic diseases.J Clin Oncol 2001 Jan 1;19(1):242-52.
    11134219
  • Goldman DP, Schoenbaum ML, Potosky AL, Weeks JC, Berry SH, Escarce JJ, Weidmer BA, Kilgore ML, Wagle N, Adams JL, Figlin RA, Lewis JH, Cohen J, Kaplan R, McCabe M.Measuring the incremental cost of clinical cancer research.J Clin Oncol 2001 Jan 1;19(1):105
    11134202
  • Wolfe J, Klar N, Grier HE, Duncan J, Salem-Schatz S, Emanuel EJ, Weeks JC.Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care.JAMA 2000 Nov 15;284(19):2469-75.
    11074776
  • Galper SR, Lee SJ, Tao ML, Troyan S, Kaelin CM, Harris JR, Weeks JC.Patient preferences for axillary dissection in the management of early-stage breast cancer.J Natl Cancer Inst 2000 Oct 18;92(20):1681-7.
    11036114
  • Guadagnoli E, Soumerai SB, Gurwitz JH, Borbas C, Shapiro CL, Weeks JC, Morris N.Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback.Breast Cancer Res Treat
    10942103
  • Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, Weeks JC.Who gets chemotherapy for metastatic lung cancer?.Chest 2000 May;117(5):1239-46.
    10807806
  • Schrag D, Kuntz KM, Garber JE, Weeks JC.Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.JAMA 2000 Feb 2;283(5):617-24.
    10665701
  • Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC.Symptoms and suffering at the end of life in children with cancer.N Engl J Med 2000 Feb 3;342(5):326-33.
    10655532
  • Lee SJ, Earle CC, Weeks JC.Outcomes research in oncology: history, conceptual framework, and trends in the literature.J Natl Cancer Inst 2000 Feb 2;92(3):195-204.
    10655436
  • Hayman JA, Hillner BE, Harris JR, Pierce LJ, Weeks JC.Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer.J Clin Oncol 2000 Jan;18(2
    10637242
  • Hillner BE, Weeks JC, Desch CE, Smith TJ.Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis.J Clin Oncol 2000 Jan;18(1):72-9.
    10623695
  • Lee SJ, Klar N, Weeks JC, Antin JH.Predicting costs of stem-cell transplantation.J Clin Oncol 2000 Jan;18(1):64-71.
    10623694
  • Ng AK, Weeks JC, Mauch PM, Kuntz KM.Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis.J Clin Oncol 1999 Jan;17(1):241-52.
    10458239
  • Rosendahl I, Kiebert GM, Curran D, Cole BF, Weeks JC, Denis LJ, Hall RR.Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. Eu
    9973095
  • Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM.Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.Ann Intern Med 1998 Nov 15;129(10):787-96.
    9841584
  • Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC.The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.Blood 1998 Dec 1;92(11):4047-52.
    9834208
  • Haidet P, Hamel MB, Davis RB, Wenger N, Reding D, Kussin PS, Connors AF, Lynn J, Weeks JC, Phillips RS.Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. St
    9753025
  • Guadagnoli E, Shapiro CL, Weeks JC, Gurwitz JH, Borbas C, Soumerai SB.The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?.Cancer 1998 Jul 15;83(2):302-9.
    9669813
  • Hayman JA, Hillner BE, Harris JR, Weeks JC.Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.J Clin Oncol 1998 Mar;16(3):1022-9.
    9508186
  • Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB.Use of breast-conserving surgery for treatment of stage I and stage II breast cancer.J Clin Oncol 1998 Jan;16(1):101-6.
    9440729
  • Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW.Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.J Clin Oncol 1998 Jan
    9440753
  • Weeks JC.Outcomes assessment in the NCCN.Oncology (Huntingt) 1997 Nov;11(11A):137-40.
    9430183
  • Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH.Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.Ann Intern Med 1997
    9412310
  • Guadagnoli E, Shapiro C, Gurwitz JH, Silliman RA, Weeks JC, Borbas C, Soumerai SB.Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer.J Clin Oncol 1997 Jun;15(6):2338-44.
    9196148
  • Hayman JA, Fairclough DL, Harris JR, Weeks JC.Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer.J Clin Oncol 1997 Mar;15(3):1252-60.
    9060570
  • O'Leary JF, Fairclough DL, Jankowski MK, Weeks JC.Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship.Med Decis Making 1995 Apr-Jun;15(2):132-7.
    7783573
  • Le PP, Kohane IS, Weeks JC.Using a pen-based computer to collect health-related quality of life and utilities information.Proc Annu Symp Comput Appl Med Care 1995:839-43.
    8563410
  • Weeks JC.Preferences of older cancer patients: can you judge a book by its cover?.J Natl Cancer Inst 1994 Dec 7;86(23):1743-4.
    7966406
  • Weeks JC, Tierney MR, Weinstein MC.Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.N Engl J Med 1991 Jul 11;325(2):81-6.
    1904989
  • Weeks JC, Yeap BY, Canellos GP, Shipp MA.Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.J Clin Oncol 1991 Jul;9(7):1196-203.
    1710656